Improved Access to Genetics Care is Needed to Address Health Inequities in ATTRv Amyloidosis.

Autor: Liou L; The School of Medicine at Mount Sinai, New York, NY (L.L.)., Maurer MS; The Cardiac Amyloidosis Program, Columbia University Irving Medical Center, New York Presbyterian Hospital (M.S.M.)., Kontorovich AR; Fuster Heart Hospital, Cardiovascular Research Institute, Institute for Genomic Health at Icahn School of Medicine at Mount Sinai, New York, NY (A.R.K.).
Jazyk: angličtina
Zdroj: Circulation [Circulation] 2024 Oct; Vol. 150 (14), pp. 1072-1074. Date of Electronic Publication: 2024 Sep 30.
DOI: 10.1161/CIRCULATIONAHA.124.070525
Abstrakt: Competing Interests: Dr Kontorovich reports grant support from NIH R01HL155356 and Akcea Pharmaceuticals and has received a Speaker’s honorarium from Ambry Genetics. Dr Maurer reports grant support from NIH R01HL139671 and AG081582 and grants from Alnylam, BridgeBio, Attralus, Intellia, and Ionis; and personal fees from Alnylam, Novo-Nordisk, Astra Zeneca, Ionis, and Intellia.
Databáze: MEDLINE